ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,000.00
-0.94%
Dow Jones
40,287.53
-0.93%
Brent Oil
82.15
-0.16%
Bitcoin
67,308.79
-1.24%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Aerovate Therapeutics Inc (AVTE) Quote

Aerovate Therapeutics Inc

Aerovate Therapeutics Inc (AVTE)

NASDAQ
1.78
-0.04
(-2.20%)
Closed July 22 4:00PM
Delayed by 15 minutes
1.77
-0.01
(-0.56%)
After Hours: 7:59PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
1.78
Bid
1.75
Ask
2.80
Volume
250,514
1.77 Day's Range 1.88
1.25 52 Week Range 32.415
Market Cap
52.431M
Previous Close
1.82
Open
1.83
Last Trade
6
@
1.76
Last Trade Time
Financial Volume
$ 459,357
VWAP
1.8337
Average Volume (3m)
1,208,735
Shares Outstanding
28,808,334
Dividend Yield
-
PE Ratio
-0.68
Earnings Per Share (EPS)
-2.62
Revenue
-
Net Profit
-75.52M

About Aerovate Therapeutics Inc

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hyper... Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.aerovatetx.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Aerovate Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVTE. The last closing price for Aerovate Therapeutics was $1.82. Over the last year, Aerovate Therapeutics shares have traded in a share price range of $ 1.25 to $ 32.415.

Aerovate Therapeutics currently has 28,808,334 shares outstanding. The market capitalization of Aerovate Therapeutics is $52.43 million. Aerovate Therapeutics has a price to earnings ratio (PE ratio) of -0.68.

AVTE Latest News

More News

Form 8-K - Current report

July 08 2024
Edgar (US Regulatory)

Aerovate Therapeutics to Explore Strategic Alternatives

WALTHAM, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), which previously announced it was halting enrollment and shutting down the Phase 3 portion of the...

July 08 2024
GlobeNewswire Inc.

Form 8-K - Current report

June 17 2024
Edgar (US Regulatory)

Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension

WALTHAM, Mass., June 17, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE) today announced topline results from the Phase 2b portion of the Inhaled iMatinib Pulmonary Arterial...

June 17 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

June 14 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 14 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

June 14 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

June 13 2024
Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933

June 10 2024
Edgar (US Regulatory)

Form 8-K - Current report

June 07 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.12-6.315789473681.921.744453291.87898557CS
40.1811.251.621.3613854581.63468618CS
12-19.79-91.747797867421.5725.2851.2512087353.75414992CS
26-18-91.001011122319.7832.4151.256309196.29617671CS
52-13.93-88.669637173815.7132.4151.253507327.26557817CS
156-12.74-87.74104683214.5232.4151.2518201211.11513991CS
260-26.22-93.64285714292832.4151.2518152711.23456846CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SERVServe Robotics Inc
$ 7.51
(185.55%)
266.26M
AUGXAugmedix Inc
$ 2.27
(147.71%)
24.14M
XCURExicure Inc
$ 0.5351
(76.02%)
14.02M
PSNLPersonalis Inc
$ 3.83
(56.33%)
22.8M
MDBHMDB Capital Holdings LLC
$ 10.675
(37.21%)
126.45k
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
124.61M
HYZNHyzon Motors Inc
$ 0.149
(-47.54%)
23.63M
MEDSTRxADE Health Inc
$ 14.92
(-33.45%)
223.27k
SILOSilo Pharma Inc
$ 2.50
(-27.95%)
11.93M
KITTNauticus Robotics Inc
$ 0.0935
(-27.46%)
28.43M
SERVServe Robotics Inc
$ 7.51
(185.55%)
266.26M
SXTP60 Degrees Pharmaceuticals Inc
$ 0.2602
(5.77%)
226.82M
NVDANVIDIA Corporation
$ 117.93
(-2.61%)
217.11M
SQQQProShares UltraPro Short QQQ
$ 8.46
(2.79%)
188.2M
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
124.61M

Discussion

View Full Feed
Squirrely_McShitty Squirrely_McShitty 7 minutes ago
60% - 40% positive.
CNNA
MrMyers MrMyers 8 minutes ago
Thank you canthelpit. The only silver lining is being able to follow .0000 trades with .0001 bids that are filled below .0001. Doesn’t happen very often.
GTCH
MrMyers MrMyers 12 minutes ago
$GTB TECH posted on LinkedIn this afternoon. The post addresses 1) the immense importance of cybersecurity, 2) and the company’s expertise in the field of cybersecurity to provide solutions. GBT TECH does indeed have cybersecurity intellectual property. My hope and prayer is that GBT TECH will ass
GTB
gimmee greenbacks gimmee greenbacks 13 minutes ago
10,000 new reads in the last two hours
to over 222,000 reads on Most Read Boards..




BIEL
BIEL
DD_dempsey DD_dempsey 15 minutes ago
Intriguing updates for $HIRU - patiently holding

I have held this stock now for 7 years and clearly - if this ends up being the reason why … a few ownerships and managements later - than so be it.

I can’t deny the last three sessions here as I went from Red to Green a
HIRU
236T568 236T568 17 minutes ago
The Anti-Trump

https://x.com/harryjsisson/status/1815095062512230855
236T568 236T568 19 minutes ago
There you go

https://x.com/MaryLTrump/status/1815136551984402819
sylvia07 sylvia07 21 minutes ago
How uplisting to a major exchange works and requirements...........
https://foundershield.com/blog/how-uplisting-stocks-works/
GRST
littlejohn littlejohn 25 minutes ago
call me nuts, SMCI to 1,200 this week

could be possible...

it could need some money rolling off

TSLA on Wednesday over to SMCI

to have a chance...

another article on new Nasdaq 100 entry...

https://finance.yaho
SMCI TSLA
Hanibal Hanibal 29 minutes ago
Lol. GOP in disarray. Let it all out big fella.

Not sure how you typed this out with a straight face considering it's Trump's MO

Elitist at their best, me,me, me, and me. No one else in the Country exists,
sylvia07 sylvia07 31 minutes ago
Sad but true!
GRST
kabunushi kabunushi 35 minutes ago
In any case imo the dude is off his rocker now, obsessively hating on people on this MB. Not at all the sign of a healthy individual dealing with whatever may have happened and moving on with his/her life as I would expect any normal person to. Whatever happened or didn't happen to him he's stuck in
NWBO
Louinjaxxx Louinjaxxx 37 minutes ago
Technically always has been Pink Current Information....just a matter of syncing report filings. Only nervous nancies and bashers are concerned.
AXXA
sage4 sage4 39 minutes ago
That makes total sense. A good strategic plan.
AVXL
sctts sctts 39 minutes ago
$$$ Today is the Day $$$$

$$$$ $frx $$$$
FRX
sage4 sage4 43 minutes ago
Now you are talking
AVXL
flipper44 flipper44 59 minutes ago
I played your post backwards and finally understood it.

Sprechen sie geek?
NWBO
nowwhat2 nowwhat2 60 minutes ago
Nite nite

https://investorshub.advfn.com/uimage/uploads/2024/7/22/uhombBTC_777_21_6M_11PM_OHTL_RESIST_2021.jpg



https://investorshub.advfn.com/uimage/uploads/2024/7/21/vromubtc_777_21_45d_8pm_w_666_10_1245_eth_etf.jpg



BTCUSD
Peeteman Peeteman 1 hour ago
Pink Current now from what I see?
AXXA
littlejohn littlejohn 1 hour ago
China central bank cuts rates by 10

basis points today,

after Biden dropped out of race and

endorsed bad Karma...


Two items may not be related other than

timing to get ahead of potential fall out of

U
KILLAZILLA KILLAZILLA 1 hour ago
WRONG!!!
https://www.wsj.com/video/kamala-harris-calls-out-joe-biden-over-racial-issues/DAA0D8FE-AF38-47A0-A8F6-E1B6E04B2BFC
Real McCoy Real McCoy 1 hour ago
If it was actually confidential, no one including you would know.
VeronicaFox VeronicaFox 1 hour ago
Past ”Shortcomings”??? lol, that’s like saying a 100 mile hike is just a little jog. Scozzafava has destroyed numerous companies and left those shareholders in financial ruin. He has one of the highest R/S rates in the OTC, and has diluted every company he ran - this one is sitting in trips. Here
ALRN
Bob Mullet Bob Mullet 1 hour ago
To da mooooooonn!!!!

SOON??!?
KBLB

Your Recent History

NASDAQ
AVTE
Aerovate Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved